NRX Pharmaceuticals Inc (NRXP)

$NRXP 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Big Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Big Rock Partners' management team includes Richard Ackerman, Chairman, President, and Chief Executive Officer, and Bennett Kim, Chief Financial Officer, Chief Investment Officer, Corporate Secretary and Director.

$2B

Total Revenue

2

Employees

$1B

Market Capitalization

5.05

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 21578 2286 2.88 20.15 13.26
Organon & Co. OGN 7323 7878 -4.52 4.82 19.26
Arvinas Inc ARVN 3963 23 4.93 -19.95 -794.96
Tilray Inc TLRY 2976 564 0.99 -7.48 -66.49
Usana Health Sciences Inc USNA 2097 1230 4.87 15.27 11.04
ATAI Life Sciences N.V. ATAI 1782 20 3.94 -10.71 -821.63
Cronos Group Inc CRON 1527 57 0.96 -10.58 -258.59
DICE Therapeutics Inc DICE 1211 1 3.72 -30.64 None
NRX Pharmaceuticals Inc NRXP 1170 2321 0.45 5.05 9.91
Intersect ENT Inc XENT 894 104 56.42 -10.10 -85.02
Ventyx Biosciences Inc VTYX 877 -10.72 -10.48 None
Phibro Animal Health Corp. PAHC 825 853 3.49 16.77 5.70
Edgewise Therapeutics Inc EWTX 793 2.79 -21.86 None
Phathom Pharmaceuticals Inc PHAT 673 5.72 -4.13 None
Theseus Pharmaceuticals Inc THRX 567 -12.12 -26.25 None
Cyteir Therapeutics Inc CYT 548 2.80 -15.36 None
Rani Therapeutics Holdings Inc RANI 514 3 9.84 -25.43 -678.00
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Pliant Therapeutics Inc PLRX 475 10 2.16 -5.04 -914.12
Fulcrum Therapeutics Inc FULC 472 18 2.59 -6.30 -409.62
Ikena Oncology Inc IKNA 465 11 2.28 -7.38 -581.21
Provention Bio Inc PRVB 399 1 3.08 -3.27 None
Rain Therapeutics Inc RAIN 350 413 2.42 -9.15 123.20
Chromadex Corp CDXC 299 65 8.71 -10.53 -42.83
Adicet Bio Inc ACET 279 10 1.52 4.84 -570.14
Verrica Pharmaceuticals Inc VRCA 241 12 6.26 -6.30 -320.98
Evolus Inc EOLS 239 86 3.10 -1.40 -162.78
Milestone Pharmaceuticals Inc MIST 231 15 1.32 -7.52 -230.90
Aquestive Therapeutics Inc AQST 194 47 -3.59 -3.11 -132.11
Terns Pharmaceuticals Inc TERN 193 1.13 -5.54 None
Cognition Therapeutics Inc CGTX 185 -2.24 -15.75 None
Opiant Pharmaceuticals Inc OPNT 150 44 3.37 120.00 3.58
Anebulo Pharmaceuticals Inc ANEB 149 7.62 -3.81 None
Citius Pharmaceuticals Inc CTXR 134 1.68 -5.85 None
Kaleido Biosciences Inc KLDO 132 1 4.80 -1.48 None
Xeris Biopharma Holdings Inc XERS 124 35 -100.00 -1.36 -265.78
scPharmaceuticals Inc SCPH 115 119 1.85 -4.10 -27.05
Kala Pharmaceuticals Inc KALA 107 12 1.84 -0.85 None
LifeMD Inc LFMD 107 78 -6.93 -0.96 -95.77
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Eyenovia Inc EYEN 94 6 24.00 -4.74 -332.81
Eton Pharmaceuticals Inc ETON 92 16 5.75 -8.36 -67.52
Natural Alternatives Internati NAII 78 177 0.97 6.99 6.64
Osmotica Pharmaceuticals Plc OSMT 76 166 1.83 -0.75 -60.32
Mannatech Inc MTEX 70 159 2.68 9.09 5.00
Odonate Therapeutics Inc ODT 58 0.83 -0.57 None
India Globalization Capital In IGC 58 0 2.05 -5.00 -981.18
Context Therapeutics Inc CNTX 57 -2.81 -8.19 None
Assertio Holdings Inc ASRT 55 108 0.65 -1.32 -28.04
Shineco Inc SISI 55 3 2.23 -1.07 None
VYNE Therapeutics Inc VYNE 46 17 0.85 -0.83 -507.13
Shineco Inc TYHT 44 3 2.17 -1.55 -159.60
Reviva Pharmaceuticals Holding RVPH 39 1.52 -4.50 None
Acasti Pharma Inc ACST 29 0 0.47 -2.16 -611.47
Bio-Path Holdings Inc BPTH 25 0 1.02 -2.73 18.96
Nabriva Therapeutics Plc NBRV 23 20 0.63 -0.37 -266.57
Baudax Bio Inc BXRX 21 1 -1.35 -0.45 9.10
Cyanotech Corp. CYAN 21 35 1.15 10.12 6.09
Lexaria Bioscience Corp LEXX 20 1 2.76 -5.10 -445.15
Dermata Therapeutics Inc DRMA 20 0.45 -2.46 None
Trevi Therapeutics Inc TRVI 19 2.16 -0.54 None
Hoth Therapeutics Inc HOTH 16 1.45 -1.50 None
Timber Pharmaceuticals Inc TMBR 13 0 11.00 3.07 -527.55
Sonoma Pharmaceuticals Inc. SNOA 9 17 3.02 -1.72 -31.96

NRX Pharmaceuticals Inc Shares Close the Day 20.0% Higher - Daily Wrap

3d ago, source: Nasdaq

NRX Pharmaceuticals Inc shares closed today 20.0% higher than it did at the end of yesterday. The stock is currently down ...

NRXP Stock Surges on Latest Covid-19 Update From NRx Pharmaceuticals

4d ago, source: Business Insider

InvestorPlace - Stock Market News, Stock Advice & Trading Tips NRx Pharmaceuticals (NASDAQ:NRXP) stock gained 50% last Friday ...

Why NRx Pharmaceuticals Stock Soared Today

3d ago, source: The Motley Fool on MSN.com

What happened  Shares of NRx Pharmaceuticals (NASDAQ: NRXP) surged on Monday after the healthcare company released promising ...

The countdown is on: NRx Pharmaceuticals Inc. (NRXP)

4d ago, source: investchronicle

NRx Pharmaceuticals Inc. (NRXP) is priced at $6.75 after the most recent trading session. At the very opening of the session, the stock price was $4.62 and reached a high price of $8.89, prior to ...

NRx Pharma's COVID-19 Vaccine Displays Effectiveness Against Delta Variant in Phase 2 Clinical Trial

3d ago, source: Middle East North Africa Financial Network

Shares of NRx Pharmaceuticals Inc. traded 50% higher after the company commented on new data released by the Israel Institute ...

At $5.94 Price, NRx Pharmaceuticals Inc. (NRXP) Sits And Waits For Direction

1d ago, source: stocksregister

NRx Pharmaceuticals Inc. (NASDAQ:NRXP) concluded the trading at $5.94 on Wednesday, December 01 with a fall of -11.08% from its closing price on previous day. Taking a look at stock we notice that its ...

Investor Trust Slackened After NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Shares Gained By $1.35

3d ago, source: marketingsentinel

NRx Pharmaceuticals Inc. (NASDAQ:NRXP) has a beta value of 0.25 and has seen 73.88 million shares traded in the last trading ...

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Are Up 16.94%, Predicting What To Expect Ahead

7d ago, source: marketingsentinel

During the recent session, NRx Pharmaceuticals Inc. (NASDAQ:NRXP)’s traded shares were 0.57 million, with the beta value of ...

NRx Soars as Drug Benefits Remdesivir-Treated Covid Patients

4d ago, source: YAHOO!Finance

NRx Pharmaceuticals Inc. soared after an analysis showed that its drug helped severely ill patients who had been treated with ...

Insiders at NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) must be relieved they sold stock as market valuation descends to US$268m

10d ago, source: Nasdaq

Insiders seem to have made the most of their holdings by selling US$83k worth of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) stock at an average sell price of US$13.11 during the past year. The company’s ...

Top Moving Stock Now – NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

4d ago, source: stocksregister

NRx Pharmaceuticals Inc. (NASDAQ:NRXP) traded at $6.75 at close of the session on Friday, 11/26/21, made an upward move of 50.00% on its previous day’s price. Looking at the stock we see that its ...

NRx Pharmaceuticals Shares Rise 18% After Zyesami Analysis

4d ago, source: MarketWatch

By Chris Wack NRx Pharmaceuticals Inc. shares were up 18%, to $7.96, after the company said it has completed an analysis to identify clinical evidence ...

Your Portfolio